Page last updated: 2024-09-03

l 158809 and saralasin

l 158809 has been researched along with saralasin in 1 studies

Compound Research Comparison

Studies
(l 158809)
Trials
(l 158809)
Recent Studies (post-2010)
(l 158809)
Studies
(saralasin)
Trials
(saralasin)
Recent Studies (post-2010) (saralasin)
137071,4971316

Protein Interaction Comparison

ProteinTaxonomyl 158809 (IC50)saralasin (IC50)
Type-1A angiotensin II receptor Rattus norvegicus (Norway rat)0.0017
Type-1B angiotensin II receptorRattus norvegicus (Norway rat)0.0017
Type-1 angiotensin II receptorHomo sapiens (human)0.0006
Type-2 angiotensin II receptorHomo sapiens (human)0.0008

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dagenais, P; Escher, E1

Other Studies

1 other study(ies) available for l 158809 and saralasin

ArticleYear
Anti-angiotensin antibodies cross-reactive with nonpeptide angiotensin antagonists as angiotensin receptor model.
    Regulatory peptides, 1993, Mar-19, Volume: 44, Issue:2

    Topics: Adrenocorticotropic Hormone; Amino Acid Sequence; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antibodies; Biphenyl Compounds; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Imidazoles; Losartan; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Naloxone; Pyridines; Saralasin; Structure-Activity Relationship; Tetrazoles

1993